The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2019

Filed:

May. 21, 2014
Applicants:

Max-planck Gesellschaft Zur Förderung Der Wissenschaften E.v., Munich, DE;

Justus-liebig-universität Giessen, Giessen, DE;

Inventors:

Guillermo Barreto, Karben, DE;

Aditi Mehta, Bad Nauheim, DE;

Indrabahadur Singh, Friedberg, DE;

Marten Szibor, Espoo, FI;

Rajkumar Savai, Bad Nauheim, DE;

Werner Seeger, Biebertal, DE;

Thomas Braun, Bad Nauheim, DE;

Andreas Günther, Polheim Watzenborn-Steinberg, DE;

Marcus Krüger, Bad Nauheim, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G01N 33/57423 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/47 (2013.01);
Abstract

The present invention relates to a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer, comprising the measurement of the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample of said subject. Furthermore, the present invention relates to a composition for use in medicine comprising (an) inhibitor(s) of specific isoforms of GATA6 and/or NKX2-1. Additionally, the present invention relates to a kit for use in a method of assessing whether a subject suffers from cancer or is prone to suffering from cancer, in particular lung cancer.


Find Patent Forward Citations

Loading…